Thiamine deficiency and its correlation with dyslipidaemia in diabetics with microalbuminuria

Journal of the Pakistan Medical Association

Volumn 63, Issue 3, 2013, Pages 340-346

  Waheed, Palvasha ^a   Naveed, Abdul Khaliq ^a   Ahmed, Tausif ^a  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

Diabetes mellitus; Dyslipidaemia; Microalbuminuria; Thiamine chloride; Thiamine monophosphate

Indexed keywords

ALBUMIN; CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAMINE; THIAMINE PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COLORIMETRY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; THIAMINE DEFICIENCY; TURBIDIMETRY;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; THIAMINE DEFICIENCY;

EID: 84874588128     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Beltramo E, Berrone E, Tarallo S, Porta M. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol 2008; 45: 131-41.
2. Tilton R, Baier L, Harlow J, Smith S, Ostrow E, Williamson J. Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD. Kidney Int 1992; 41: 778-88.
3. Nishikawa T, Edelstein D, Du X, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-90.
4. Michael M, Kulkarni R, Postic C, Previs S, Shulman G, Magnuson M, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6: 87-97.
5. Goldberg H, Scholey J, Fantus I. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 2000; 49: 863-71.
6. Yang W, Deeb S. Sp1 and Sp3 transactivate the human lipoprotein lipase gene promoter through binding to a CT element: synergy with the sterol regulatory element binding protein and reduced transactivation of a naturally occurring promoter variant. J Lipid Res 1998; 39: 2054-64.
7. Babaei-Jadidi R, Karachalias N, Kupich C, Ahmed N, Thornalley P. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 2004; 47: 2235-46.
8. Veerababu G, Tang J, Hoffman R, Daniels M, Jr LH, Crook E, et al. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. Diabetes 2000; 49: 2070-8.
9. Rumberger JM, Wu T, Hering MA, Marshall S. Role of hexosamine biosynthesis in glucose-mediated up-regulation of lipogenic enzyme mRNA levels: effects of glucose, glutamine and glucosomine on glycenaphosphate dehydregenase, fatty acid synthase, acctyl CoA carboxylase mRNA levels. J Biol Chem 2003; 278: 28547-52.
10. Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003; 52: 2110-20.
11. Fioretto P, Bruseghin M, Berto I, Gallina P, Manzato E, Mussap M. Renal protection in diabetes: role of glycemic control. J Am Soc Nephrol 2006; 17: S86-S9.
12. Barham D, Trinder P. An improved color reagent for the determination of blood glucose by the oxidase system. Analyst 1972; 97: 142-5.
13. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24-7.
14. Klenk DC, Hermanson G, Krohn R, Fujimoto E, Malia AK, Smith P. Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion exchanging methods, and effect of common interferences. Clin Chun 1982; 28: 2088-94.
15. Fossati R, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-80.
16. Naito H. "Cholesterol" in Clinical Chemistry: Theory, Analysis and Correlation. L.A. Kaplan and A.J. Pesce. St. Louis, MO: C.V. Mosby Co. Toronto. Princeton 1984; 1194-11206.
17. Warnick G, Wood P. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995; 41: 1427-33.
18. Assman G. Lipid diagnostik heute. In: Lipoprotein und. Herzinfarkt (Greten H., Lang P.D. and Schettler G., eds), Witzstrock-Verlag. Baden-Baden, Germany. 1979; 29.
19. Gerrits J, Eidhof H, Brunnekreeft J, Hessels J. Determination of thiamin and thiamin phosphates in whole blood by reversedphase liquid chromatography with precolumn derivatization. Methods Enzymol 1997; 279: 74-82.
20. Alkhalaf A, Klooster A, van Oeveren W, Achenbach U, Kleefstra N, Slingerland R, et al. A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. Diabetes Care 2010; 33: 1598-601.
21. Thornalley P, Babaei-Jadidi R, Al Ali H, Rabbani N, Antonysunil A, Larkin J, et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 2007; 50: 2164-70.
22. Rabbani N, Alam SS, Riaz S, Larkin JR, Akhtar M, Shafi T, et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebocontrolled pilot study. Diabetologia 2009; 52: 208-12.
23. Savage DB, Petersen KF, Shulman GI. Disordered Lipid Metabolism and the Pathogenesis of Insulin Resistance. Physiol Rev 2007; 87: 507-20.
24. Rivellese AA, Vaccaro O, Patti L. The pathophysiology of lipid metabolism and diabetes. International Journal of Clinical Practice 2004; 58: 32-5.
25. Thomas M, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, et al. Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care 2006; 29: 317-22.
26. Tseng C. Differential dyslipidaemia associated with albuminuria in type 2 diabetic patients in Taiwan. Clin Biochem 2009; 42: 1019-24.
27. Kohda Y, Shirakawa H, Yamane K, Otsuka K, Kono T, Terasaki F, et al. Prevention of incipient diabetic cardiomyopathy by highdose thiamine. J Toxicol Sci 2008; 33: 459-72.